Healthcare and Materials Firms Beat Targets as Consumer Segment Faces HeadwindsGlobal Report·2 days ago, 04:13 AMAGI-2.01%SENS-0.79%
VivoSim Labs faces Nasdaq delisting risk after falling below $2.5 million stockholders’ equity requirementPUBT·Jul 24 at 03:08 PMVIVS-10.73%
VivoSim Labs rises 6% in after-hours trading on volume spikeUS Stock Market Update·Jul 21 at 04:21 PMVIVS-10.73%
VivoSim Labs slides 9% after brief intraday spike amid heavy volumeUS Stock Market Update·Jul 21 at 02:51 PMVIVS-10.73%
VivoSim Labs falls 5% in regular trading on heavy volumeUS Stock Market Update·Jul 21 at 11:41 AMVIVS-10.73%
VivoSim Labs rises 0% in regular trading on volume spikeUS Stock Market Update·Jul 21 at 09:11 AMVIVS-10.73%
VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services | VIVS Stock NewsStockTitan·Jul 20 at 11:05 PMVIVS-10.73%
VivoSim Labs Prices $4.0 Million Private Placement and Amends Legacy Armistice WarrantsTradingView·Jul 17 at 07:53 AMVIVS-10.73%
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga_article·Jul 16 at 12:05 PMATPC-1.70%LIMN+0.88%